Showing 1 - 20 results of 23 for search 'Mohammad Fazle Akbar', query time: 0.07s Refine Results
  1. 1
    Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling

    Co-existence of a pandemic (SARS-CoV-2) and an epidemic (Dengue virus) at some focal points in Southeast Asia: Pathogenic importance, preparedness, and strategy of tackling by Sakirul Khan, Sheikh Mohammad Fazle Akbar, Akira Nishizono

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Unrevealing of dysregulated hub genes linked with immune system and inflammatory signaling pathways in the pathogenesis of irritable bowel syndrome by system biology approaches

    Unrevealing of dysregulated hub genes linked with immune system and inflammatory signaling pathways in the pathogenesis of irritable bowel syndrome by system biology approaches by Piplu Bhuiyan, Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines

    Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B

    Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B by Julio Cesar Aguilar, Jorge Agustin Aguiar, Sheikh Mohammad Fazle Akbar

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Cellular and Molecular Mechanisms Underlying Scope and Limitation of Ongoing and Innovative Therapies for Treating Chronic Hepatitis B

    Cellular and Molecular Mechanisms Underlying Scope and Limitation of Ongoing and Innovative Therapies for Treating Chronic Hepatitis B by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Yoichi Hiasa

    Published 2022-01-01
    Get full text
    Article
  6. 6
    Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection

    Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan, Osamu Yoshida, Yoichi Hiasa

    Published 2022-09-01
    Get full text
    Article
  7. 7
    Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection

    Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa

    Published 2023-07-01
    Get full text
    Article
  8. 8
    Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon

    Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon by Mamun Al-Mahtab, Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Julio Cesar Aguilar, Gerardo Guillen, Yoichi Hiasa

    Published 2023-05-01
    Get full text
    Article
  9. 9
    Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease.

    Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease. by Liying Yao, Masanori Abe, Keitarou Kawasaki, Sheikh Mohammad Fazle Akbar, Bunzo Matsuura, Morikazu Onji, Yoichi Hiasa

    Published 2016-01-01
    Get full text
    Article
  10. 10
    HBV genome analysis in the progression of HBV related chronic liver disease

    HBV genome analysis in the progression of HBV related chronic liver disease by Ruksana Raihan, Mamun Al Mahtab, Rosmawati Binti Mohamed, Tee Kok Keng, Shahina Tabassum, Sheikh Mohammad Fazle Akbar

    Published 2017-12-01
    Get full text
    Article
  11. 11
    Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial

    Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase II... by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa

    Published 2021-11-01
    Get full text
    Article
  12. 12
    Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment

    Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatmen... by Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, Osamu Yoshida, Sakirul Khan, Guillen Nieto Gerardo, Yoichi Hiasa

    Published 2023-02-01
    Get full text
    Article
  13. 13
    Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside

    Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan, Osamu Yoshida, Julio Cesar Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa

    Published 2022-05-01
    Get full text
    Article
  14. 14
    The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial

    The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Osamu Yoshida, Sakirul Khan, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa

    Published 2021-12-01
    Get full text
    Article
  15. 15
    Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh.

    Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh. by Ruksana Raihan, Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Kazuaki Takahashi, Junya Masumoto, Shahina Tabassum, Kok Keng Tee, Rosmawati Binti Mohamed

    Published 2019-01-01
    Get full text
    Article
  16. 16
    Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial).

    Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial). by Mamun Al Mahtab, Sheikh Mohammad Fazle Akbar, Julio Cesar Aguilar, Gerardo Guillen, Euduaro Penton, Angela Tuero, Osamu Yoshida, Yoichi Hiasa, Morikazu Onji

    Published 2018-01-01
    Get full text
    Article
  17. 17
    Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system

    Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system by Ayaka Nakanishi, Naoe Kaneko, Hiroyuki Takeda, Tatsuya Sawasaki, Shinnosuke Morikawa, Wei Zhou, Mie Kurata, Toshihiro Yamamoto, Sheikh Mohammad Fazle Akbar, Tamotsu Zako, Junya Masumoto

    Published 2018-11-01
    Get full text
    Article
  18. 18
    Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia

    Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Ferdousi Begum, Shaikh A. Shahed Hossain, Sukumar Sarker, Ananta Shrestha, Md. Sakirul Islam Khan, Osamu Yoshida, Yoichi Hiasa

    Published 2021-04-01
    Get full text
    Article
  19. 19
    Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical

    Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical by Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo, Yoichi Hiasa

    Published 2021-10-01
    Get full text
    Article
  20. 20
    Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure

    Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failur... by Abul H Manik, Debraj Malakar, Sheikh M Noor-E-Alam, Mamun A Mahtab, Dulal C Das, Ayub A Mamun, Sakirul Khan, Mohammad Fazle Akbar, Zakiur Rahman, Salimur Rahman

    Published 2021-01-01
    Get full text
    Article

Search Tools: